» Articles » PMID: 8346485

Bone Mineral Density and Body Composition in Adult Patients with Cystic Fibrosis

Overview
Journal Thorax
Date 1993 Jun 1
PMID 8346485
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cystic fibrosis is a multisystem disease characterised by chronic pulmonary sepsis and malnutrition. To ascertain whether osteoporosis is a feature of cystic fibrosis in adult patients, total body and regional bone mineral density (BMD) was measured in a group of eight men and eight women aged 17-42 years.

Methods: Total body and regional BMD (lumbar spine L2-L4, femoral neck, trochanteric, and Ward's triangle), as well as total body fat and lean mass, were measured by dual energy x ray absorptiometry. A range of biochemical, lifestyle, and anthropometric variables was also assessed.

Results: Patients with cystic fibrosis had significantly reduced bone density at all sites compared with normal young adults. The mean reductions ranged from 7% at Ward's triangle to 13% at the trochanter. Body mass index (BMI) was positively correlated with BMD at four sites and disease severity negatively correlated with BMD at two sites. Other biochemical and anthropometric variables were not predictive of bone density. Total body fat mass was reduced by 30% compared with normal young adults.

Conclusions: Bone density is decreased in adult patients with cystic fibrosis and BMI and disease severity are independent predictors of bone density.

Citing Articles

Vasoactive intestinal peptide and cystic fibrosis transmembrane conductance regulator contribute to the transepithelial calcium transport across intestinal epithelium-like Caco-2 monolayer.

Rodrat M, Wongdee K, Teerapornpuntakit J, Thongbunchoo J, Tanramluk D, Aeimlapa R PLoS One. 2022; 17(11):e0277096.

PMID: 36399482 PMC: 9674163. DOI: 10.1371/journal.pone.0277096.


An update on methods for assessing bone quality and health in Cystic fibrosis.

Williams K, Darukhanavala A, Hicks R, Kelly A J Clin Transl Endocrinol. 2022; 27:100281.

PMID: 34984171 PMC: 8693345. DOI: 10.1016/j.jcte.2021.100281.


Evaluation of bone disease in patients with cystic fibrosis and end-stage lung disease.

Robinson C, Hofer M, Benden C, Schmid C J Bras Pneumol. 2019; 45(1):e20170280.

PMID: 30843951 PMC: 6534402. DOI: 10.1590/1806-3713/e20170280.


Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients.

Ho C, Hayes Jr D, Khosravi M, Splaingard M, Tumin D, Lloyd E Lung. 2018; 196(4):435-439.

PMID: 29797070 DOI: 10.1007/s00408-018-0119-5.


Trends in bone mineral density in young adults with cystic fibrosis over a 15 year period.

Putman M, Baker J, Uluer A, Herlyn K, Lapey A, Sicilian L J Cyst Fibros. 2015; 14(4):526-32.

PMID: 25698451 PMC: 4485936. DOI: 10.1016/j.jcf.2015.01.011.


References
1.
Bonjour J, Theintz G, Buchs B, Slosman D, Rizzoli R . Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab. 1991; 73(3):555-63. DOI: 10.1210/jcem-73-3-555. View

2.
Mischler E, Chesney P, Chesney R, Mazess R . Demineralization in cystic fibrosis detected by direct photon absorptiometry. Am J Dis Child. 1979; 133(6):632-5. DOI: 10.1001/archpedi.1979.02130060072016. View

3.
Solomons N, Wagonfeld J, Rieger C, Jacob R, Bolt M, HORST J . Some biochemical indices of nutrition in treated cystic fibrosis patients. Am J Clin Nutr. 1981; 34(4):462-74. DOI: 10.1093/ajcn/34.4.462. View

4.
Foresta C, Ruzza G, Mioni R, Meneghello A, Baccichetti C . Testosterone and bone loss in Klinefelter syndrome. Horm Metab Res. 1983; 15(1):56-7. DOI: 10.1055/s-2007-1018630. View

5.
Desmond K, Schwenk W, Thomas E, Beaudry P, Coates A . Immediate and long-term effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr. 1983; 103(4):538-42. DOI: 10.1016/s0022-3476(83)80579-4. View